Journal Article

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

Kahkoska, Anna R., Semnani-Azad, Zhila, Leung, Gloria K. W., Rooney, Mary R., de Souza, Russell, Morton, Robert W., Hughes, Alice, Fitzpatrick, Stephanie L., Franks, Paul W., Lowe, William L., Reynolds, Rebecca M., Vesco, Kimberly K., Urazbayeva, Marzhan, Lim, Siew S., Cromer, Sara J., Hattersley, Andrew T., Goodarzi, Mark O., Saeed, Zeb, Leong, Aaron, Miller, Rachel G., Dickens, Laura T., Ukke, Gebresilasea Gendisha, Wagner, Robert, Corcoy, Rosa, Fitipaldi, Hugo, Schön, Martin, Libman, Ingrid M., Takele, Wubet Worku, Chen, Mingling, Dawed, Adem Y., Flanagan, Sarah E., Koivula, Robert W., Steck, Andrea K., Hannah, Wesley, Zhang, Yingchai, Most, Jasper, Gaillard, Romy, Dabelea, Dana, Tobias, Deirdre K., Pilla, Scott J., Colclough, Kevin, Pratley, Richard E., Guasch-Ferré, Marta, Stanislawski, Maggie A., Ray, Debashree, Francis, Ellen C., Petrie, John R., Udler, Miriam S., Rich, Stephen S., Nolan, John J., Ikle, Jennifer M., McGovern, Andrew, Pearson, Ewan R., Clark, Amy L., Jacobsen, Laura M., Njølstad, Pål Rasmus, Duan, Daisy, Ismail, Heba M., Young, Katherine, Vilsbøll, Tina, Chivers, Sian C., Pomares-Mi

2023

Overview

Precision medicine is part of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and optimize outcomes when making medical decisions and health recommendations. Diabetes affects hundreds of millions of people worldwide, many of whom will develop life-threatening complications and die prematurely. Precision medicine can potentially address this enormous problem by accounting for heterogeneity in the etiology, clinical presentation and pathogenesis of common forms of diabetes and risks of complications. This second international consensus report on precision diabetes medicine summarizes the findings from a systematic evidence review across the key pillars of precision medicine (prevention, diagnosis, treatment, prognosis) in four recognized forms of diabetes (monogenic, gestational, type 1, type 2). These reviews address key questions about the translation of precision medicine research into practice. Although not complete, owing to the vast literature on this topic, they revealed opportunities for the immediate or near-term clinical implementation of precision diabetes medicine; furthermore, we expose important gaps in knowledge, focusing on the need to obtain new clinically relevant evidence. Gaps include the need for common standards for clinical readiness, including consideration of cost-effectiveness, health equity, predictive accuracy, liability and accessibility. Key milestones are outlined for the broad clinical implementation of precision diabetes medicine. A systematic review of evidence, across the key pillars of prevention, diagnosis, treatment and prognosis, outlines milestones that need to be met to enable the broad clinical implementation of precision medicine in diabetes care.

• Publisher: Nature Publishing Group US,Nature Publishing Group
• Subject: 692/308 / 692/308/575 / Biomedical and Life Sciences / Biomedicine / Cancer Research / Clinical Medicine / Consensus / Consensus Statement / Diabetes / Diabetes mellitus (insulin dependent) / Diabetes mellitus (non-insulin dependent) / Diabetes Mellitus - diagnosis / Diabetes Mellitus - genetics / Diabetes Mellitus - therapy / Diagnosis / Endocrinology and Diabetes / Endokrinologi och diabetes / Evidence-Based Medicine / Health services / Heterogeneity / Humans / Infectious Diseases / Klinisk medicin / Medical and Health Sciences / Medicin och hälsovetenskap / Metabolic Diseases / Molecular Medicine / Neurosciences / Pathogenesis / Precision Medicine / Prevention / Prognosis / Translation